Bioinorganic Chemistry and Applications · 2008 · 14 citations · 22 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyChemotherapyApoptosis In CancerApoptosis PharmacologyCytotoxic ChemotherapyMalignant NeoplasmsMolecular Mechanisms Of ToxicityAntineoplastic Drug TherapyCellular AccumulationCellular Drug AccumulationChemotherapy-induced ApoptosisCytotoxicity AssaysIn-vitro CharacterizationPlatinum CompoundsPlatinum-based Agents
The antineoplastic potential of a stable monomeric Au(II) complex with hematoporphyrin IX (Hp), namely [Au(II)Hp(-2H).(H(2)O)(2)], was investigated in a panel of tumor cell lines. The complex exhibits strong cytotoxicity, whereby the leukaemia- and lymphoma-derived cell lines are more sensitive, with IC(50) values comparable to those of the reference anticancer drug cisplatin. In contrast, the solid tumor models are more sensitive to the platinum drug. A comparative assessment of both agents against the human kidney cell line 293T has shown that [Au(II)Hp(-2H).(H(2)O)(2)] is less cytotoxic. The gold complex induces oligonucleosomal DNA fragmentation in tumour cells following 24-hour treatment and hence its cytotoxic effect is at least partly mediated by induction of apoptotic cell death. A prominent intracellular gold accumulation was detected after treating tumor cells with [Au(II)Hp(-2H).(H(2)O)(2)] which shows that its putative pharmacological targets are readily accessible after a short incubation period.
22
Cisplatin and platinum drugs at the molecular level (Review)
Teni Boulikas, Maria Vougiouka · Oncology Reports · 2003 · 728 citations
Medicine, Oncology, Pharmacology +14
Metals and metal compounds in cancer treatment.
B Desoize · PubMed · 2004 · 278 citations
Medicine, Oncology, Pharmacology +11